JNJ vs ABBV: Which Stock is Better?
Side-by-side comparison of Johnson & Johnson and Abbvie Inc in 2026
JNJ
Johnson & Johnson
$239.63
ABBV
Abbvie Inc
$232.35
Key Metrics Comparison
| Metric | JNJ | ABBV | Winner |
|---|---|---|---|
| Market Cap | $577.48B | $410.83B | JNJ |
| P/E Ratio | 22.23 | 98.04 | JNJ |
| EPS (TTM) | $10.78 | $2.37 | JNJ |
| Revenue Growth | 0.1% | 0.1% | ABBV |
| Gross Margin | 68.1% | 71.6% | ABBV |
Analyze JNJ
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is JNJ or ABBV a better investment?
Comparing JNJ and ABBV: Johnson & Johnson has a market cap of $577.48B while Abbvie Inc has $410.83B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between JNJ and ABBV?
JNJ (Johnson & Johnson) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: JNJ or ABBV?
Based on P/E ratios, JNJ trades at a lower multiple (22.2x vs 98.0x).
Which is growing faster: JNJ or ABBV?
ABBV has higher revenue growth at 0.1% vs 0.1% for JNJ.
Which company is more profitable: JNJ or ABBV?
Abbvie Inc (ABBV) has higher gross margins at 71.6% compared to 68.1% for JNJ.
Which is the larger company: JNJ or ABBV?
Johnson & Johnson (JNJ) is larger with a market cap of $577.48B compared to $410.83B for ABBV.
Should I buy JNJ or ABBV in 2026?
Both JNJ and ABBV have investment merit. JNJ trades at $239.63 while ABBV trades at $232.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between JNJ and ABBV stock?
Key differences: Market Cap ($577.48B vs $410.83B), P/E Ratio (22.2x vs 98.0x), Revenue Growth (0.1% vs 0.1%), Gross Margin (68.1% vs 71.6%).